SCHEMBL24620199

SCHEMBL24620199

C=C1NCc2cccc(Nc3nc(C)ncc3C)c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 1/20 0.34
▸ SYK P43405 2/20 0.34
▸ AURKA O14965 2/20 0.33
▸ MAPK3 P27361 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ PKMYT1 Q99640 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ PIK3CA P42336 4/20 0.32
▸ PIK3CD O00329 3/20 0.32
▸ PIK3CB P42338 3/20 0.32
▸ PIK3CG P48736 3/20 0.32
▸ CDK9 P50750 3/20 0.31
▸ CDK7 P50613 1/20 0.31
▸ CCNA2 P20248 3/20 0.31
▸ CDK2 P24941 3/20 0.31
▸ CCNK O75909 2/20 0.31
▸ CCND3 P30281 2/20 0.31
▸ CDK6 Q00534 2/20 0.31
▸ JAK1 P23458 1/20 0.30
▸ JAK3 P52333 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24620485 0.78 BTK (0.47) —
SCHEMBL24620202 0.76 MAP4K1 (0.41) IGF1RPKMYT1
SCHEMBL24620276 0.74 BTK (0.45) CDK6
SCHEMBL24620354 0.72 BRD4 (0.47) IGF1RCDK9CCNA2CDK2CCNK
SCHEMBL12279165 0.71 TP53 (0.49) MAPK1
SCHEMBL24620137 0.71 BRD4 (0.38) MAPK3MAPK1MAP2K1JAK1JAK3
SCHEMBL24620488 0.71 MAP4K1 (0.42) —
SCHEMBL12279154 0.69 EGFR (0.53) —
SCHEMBL20725590 0.69 AURKA (0.39) AURKA
SCHEMBL24620455 0.68 MAP4K1 (0.51) MAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147622-A1 ISOINDOLINONE AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-07-14 — — WO disclosed
Send feedback